Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0451641 (
urolithiasis
)
3,973
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The study aimed at evaluating the proximal tubule function in patients with active metabolic
urolithiasis
with the assay of
beta 2-microglobulin
in the urine. The studies involved 30 patients with
urolithiasis
associated with chronic pyelonephritis and 31 patients with
urolithiasis
without pyelonephritis. Fifty healthy individuals served as a control group. Serum and urine
beta 2-microglobulin
concentrations were assayed with radioimmunological technique in all persons. Clearance of this microglobulin and tubular reabsorption were calculated. It was found that
beta 2-microglobulin
excretion with the urine is significantly higher in patients with metabolically active
urolithiasis
accompanied by the chronic pyelonephritis.
beta 2-microglobulin
clearance was significantly higher and tubular reabsorption significantly lower than those in patients without pyelonephritis and in control group. These finding suggest a dysfunction of the proximal tubule in patients with
urolithiasis
produced by the chronic inflammatory process in the urinary system. Negative correlation between blood serum
beta 2-microglobulin
levels and creatinine clearance was shown. Therefore, serum
beta 2-microglobulin
concentrations may be of value in evaluation of the glomerular filtration rate.
...
PMID:[Usefulness of determining beta-2-microglobulin in serum and urine in patients with metabolically active kidney calculi and healthy individuals]. 817 Aug 11